Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Dowling WE"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Cable J; PhD Science Writer, New York, New York, USA., Fauci A; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA., Dowling WE; Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway., Günther S; Bernhard Nocht Institute for Tropical Medicine and German Center for Infection Research, Hamburg, Germany., Bente DA; University of Texas Medical Branch, Galveston National Laboratory, Galveston, Texas, USA.; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California, USA., Yadav PD; Indian Council of Medical Research-National Institute of Virology, Pune, India., Madoff LC; Department of Medicine, University of Massachusetts Chan School of Medicine, Worcester, Massachusetts, USA., Wang LF; Duke-NUS Medical School, Singapore., Arora RK; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.; Institute of Biomedical Engineering, University of Oxford, Oxford, UK., Van Kerkhove M; World Health Organization, Geneva, Switzerland., Chu MC; Colorado School of Public Health, Anschutz Medical Campus, Aurora, Colorado, USA., Jaenisch T; Colorado School of Public Health, Anschutz Medical Campus, Aurora, Colorado, USA., Epstein JH; EcoHealth Alliance, New York, New York, USA., Frost SDW; Microsoft Research, Redmond, Washington, USA., Bausch DG; FIND, the global alliance for diagnostics, Geneva, Switzerland., Hensley LE; Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia.; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA., Bergeron É; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Sitaras I; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Gunn MD; Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA., Geisbert TW; University of Manitoba, Winnipeg, Manitoba, Canada.; Galveston National Laboratory and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA., Muñoz-Fontela C; Bernhard Nocht Institute for Tropical Medicine and German Center for Infection Research, Hamburg, Germany., Krammer F; Department of Microbiology and Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., de Wit E; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA., Nordenfelt P; Department of Clinical Sciences Lund, Infection Medicine, Faculty of Medicine, Lund University, Lund, Sweden., Saphire EO; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA., Gilbert SC; Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Corbett KS; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Branco LM; Zalgen Labs, Germantown, Maryland, USA., Baize S; Unité de Biologie des Infections Virales Emergentes, Institut Pasteur, Lyon, France.; Centre International de Recherche en Infectiologie (CIRI), Lyon, France.; INSERM, Ecole Normale Supérieure de Lyon, Université de Lyon, Lyon, France., van Doremalen N; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA., Krieger MA; Laboratory for Applied Science and Technology in Health, Carlos Chagas Institute, Oswaldo Cruz Foundation - Paraná, Curitiba, Brazil.; Integrated Translational Program in Chagas Disease from Fiocruz (Fio-Chagas), Oswaldo Cruz Foundation - Rio de Janeiro, Rio de Janeiro, Brazil., Clemens SAC; Oxford Vaccine Group, Oxford University, Oxford, UK.; Institute for Global Health, University of Siena, Siena, Italy., Hesselink R; Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway., Hartman D; Bill & Melinda Gates Foundation, Seattle, Washington, USA.
Publikováno v:
Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2022 Dec; Vol. 1518 (1), pp. 209-225. Date of Electronic Publication: 2022 Oct 02.
Autor:
Sitaras I; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. isitara1@jh.edu., Jacobsen H; Department of Viral Immunology, Helmholtz Centre for Infection Research, Braunschweig, Germany., Higdon MM; International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Dowling WE; Coalition for Epidemic Preparedness Innovations, Washington DC, USA., Bar-Zeev N; International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Deloria Knoll M; International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Publikováno v:
NPJ vaccines [NPJ Vaccines] 2022 Nov 15; Vol. 7 (1), pp. 147. Date of Electronic Publication: 2022 Nov 15.
Autor:
Cross RW; Galveston National Laboratory, and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America., Longini IM; Department of Biostatistics, University of Florida, Gainesville, Florida, United States of America., Becker S; Institute for Virology, Philipps-Universität Marburg, Marburg, Germany., Bok K; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Boucher D; U.S. COVID-19 Response at U.S. Department of Health and Human Services, Washington, DC, United States of America., Carroll MW; Pandemic Sciences Institute, Nuffield Department of Medicine, Oxford University, United Kingdom., Díaz JV; World Health Organization, Geneva, Switzerland., Dowling WE; Coalition for Epidemic Preparedness Innovations (CEPI), Washington, Washington, DC, United States of America., Draghia-Akli R; Johnson & Johnson-Global Public Health Research and Development, Spring House, Pennsylvania, United States of America., Duworko JT; Partnership for Research on Infectious Diseases in Liberia, Monrovia, Liberia., Dye JM; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America., Egan MA; Auro Vaccines, Pearl River, New York, United States of America., Fast P; IAVI, New York, New York, United States of America., Finan A; Sabin vaccine Institute, Washington, DC, United States of America., Finch C; Sabin vaccine Institute, Washington, DC, United States of America., Fleming TR; University of Washington, Seattle, Washington, United States of America., Fusco J; Public Health Vaccines, Cambridge, Massachusetts, United States of America., Geisbert TW; Galveston National Laboratory, and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America., Griffiths A; National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Maryland, United States of America., Günther S; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany., Hensley LE; Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, United States of America., Honko A; National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Maryland, United States of America., Hunegnaw R; Immune Biology of Retroviral Infection Section, Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America., Jakubik J; Sabin vaccine Institute, Washington, DC, United States of America., Ledgerwood J; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Luhn K; Janssen Vaccines & Prevention, Leiden, the Netherlands., Matassov D; Auro Vaccines, Pearl River, New York, United States of America., Meshulam J; Auro Vaccines, Pearl River, New York, United States of America., Nelson EV; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany., Parks CL; IAVI, New York, New York, United States of America., Rustomjee R; Sabin vaccine Institute, Washington, DC, United States of America., Safronetz D; Zoonotic Diseases and Special Pathogens Division, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Schwartz LM; World Health Organization, Geneva, Switzerland., Smith D; Bacterial and Combination Vaccines, Public Health Agency of Canada, Ottawa, Ontario, Canada., Smock P; Sabin vaccine Institute, Washington, DC, United States of America., Sow Y; Collaborative Clinical Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America., Spiropoulou CF; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Sullivan NJ; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Warfield KL; Emergent BioSolutions, Gaithersburg, Maryland, United States of America., Wolfe D; Bacterial and Combination Vaccines, Public Health Agency of Canada, Ottawa, Ontario, Canada., Woolsey C; Galveston National Laboratory, and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America., Zahn R; Janssen Vaccines & Prevention, Leiden, the Netherlands., Henao-Restrepo AM; World Health Organization, Geneva, Switzerland., Muñoz-Fontela C; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany., Marzi A; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America.
Publikováno v:
PLoS pathogens [PLoS Pathog] 2022 Oct 13; Vol. 18 (10), pp. e1010805. Date of Electronic Publication: 2022 Oct 13 (Print Publication: 2022).
Autor:
Finch CL; Sabin Vaccine Institute, Washington, DC 20037, USA., Dowling WE; Coalition for Epidemic Preparedness Innovations, Washington, DC 20006, USA., King TH; Sabin Vaccine Institute, Washington, DC 20037, USA., Martinez C; Sabin Vaccine Institute, Washington, DC 20037, USA., Nguyen BV; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services, Washington, DC 20201, USA., Roozendaal R; Janssen Vaccines and Prevention B.V., Leiden Archimedesweg 4, 2333 CN Leiden, The Netherlands., Rustomjee R; Sabin Vaccine Institute, Washington, DC 20037, USA., Skiadopoulos MH; Microvirion Vaccine Consulting, Rockville, MD 20852, USA., Vert-Wong E; Sabin Vaccine Institute, Washington, DC 20037, USA., Yellowlees A; Quantics Biostatistics, Edinburgh EH3 8EG, UK., Sullivan NJ; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Publikováno v:
Vaccines [Vaccines (Basel)] 2022 Aug 25; Vol. 10 (9). Date of Electronic Publication: 2022 Aug 25.
Autor:
Taylor KL; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Lanning L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA., Wolfraim L; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Shrivastava Gales S; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Sico C; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Dowling WE; Coalition for Epidemic Preparedness Innovations, Washington, DC 20006, USA., Ward LA; U.S. Department of Defense (DOD), Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), Joint Project Manager for Chemical, Biological, Radiological and Nuclear Medical (JPM CBRN Medical), Fort Detrick, MD 21702, USA., Florence WC; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Nuzum E; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Bryant PR; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Publikováno v:
Vaccines [Vaccines (Basel)] 2022 Jul 28; Vol. 10 (8). Date of Electronic Publication: 2022 Jul 28.